Lung microdialysis study of florfenicol in pigs after single intramuscular administration

B Yang1, J D Gao2, X Y Cao3

  • 1Hubei Engineering Research Center of Viral Vector, Wuhan Institute of Bioengineering, Wuhan, China.

Insights

This study investigated florfenicol (FF) pharmacokinetics in pig lung interstitial fluid. FF showed rapid distribution and slow elimination, crucial for optimizing antibacterial efficacy in lung infections.

Area of Science:

  • Veterinary Pharmacology
  • Antimicrobial Pharmacokinetics
  • Respiratory Tract Infections

Background:

  • Lung interstitial fluid drug concentration is key for antibacterial efficacy.
  • Florfenicol (FF) is used for bacterial lung infections.
  • Understanding FF's behavior in lung tissue is vital for treatment.

Purpose of the Study:

  • To determine the pharmacokinetic profile of florfenicol (FF) in porcine lung interstitial fluid.
  • To evaluate FF's distribution and elimination after intramuscular administration.
  • To provide data for optimizing FF dosage regimens in pigs.

Main Methods:

  • Intramuscular administration of FF (20 and 50 mg/kg) to twelve pigs.
  • Lung microdialysis probe implantation and perfusion (1 μL/min).
  • High-performance liquid chromatography (HPLC) analysis of microdialysis samples.
  • Noncompartmental pharmacokinetic analysis.

Main Results:

  • Florfenicol exhibited rapid distribution and slow elimination in lung interstitial fluid.
  • Key parameters like Cmax, Tmax, and AUC were dose-dependent.
  • Half-life (t1/2) ranged from 7.75 to 9.47 hours, indicating sustained presence.

Conclusions:

  • Florfenicol demonstrates favorable pharmacokinetic properties in porcine lung interstitial fluid.
  • The data supports the use of FF for treating bacterial lung infections in pigs.
  • Further studies can refine dosing strategies based on these findings.

Related Concept Videos